IP Library Granted Patent US 8,921,324
Granted Patent B2
US 8,921,324 · App. 13/757,148 · Granted Dec 30, 2014

Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides

Inventors: Pasit Phiasivongsa (Brentwood, CA); Louis C. Sehl (Redwood City, CA); William Dean Fuller (San Diego, CA); Guy J. Laidig (Menlo Park, CA)
Assignee: Onyx Therapeutics, Inc.
C07K5/1016C07K1/306C07C51/412C07D301/03A61K38/00C07D303/36C07D301/00C07K5/1008C07K1/1075C07C53/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,921,324
App. No.
13/757,148
Granted
Dec 30, 2014
Kind
B2
Abstract

The invention relates to crystalline peptide keto epoxide compounds, methods of their preparation, and related pharmaceutical compositions. This invention also relates to methods for the preparation of amino acid keto-epoxides. Specifically, allylic ketones are stereoselectively converted to the desired keto epoxides.

Claims (18)

1. A method for preparing a crystalline salt of a compound of Formula (II)

wherein the salt is a citrate salt; and

the method comprises (i) preparing a solution of a compound of Formula (II) in an organic solvent; (ii) adding citric acid; (iii) bringing the solution to supersaturation to cause formation of crystals; and (iv) isolating the crystals, wherein said crystalline compound has 2θ values of 4.40; 7.22; 9.12; 12.36; 13.35; 14.34; 15.54; 16.14; 16.54; 17.00; 18.24; 18.58; 19.70; 19.90; 20.30; 20.42; 21.84; 22.02; 23.34; 23.84; 24.04; 24.08; 24.48; 24.76; 25.48; 26.18; 28.14; 28.20; 28.64; 29.64; 31.04; 31.84; 33.00; 33.20; 34.06; 34.30; 34.50; 35.18; 37.48; 37.90; and 39.48.

2. A method of claim 1 , wherein the organic solvent is selected from diethyl ether, THF, acetonitrile, and MTBE, or any combination thereof.

3. A method of claim 2 , wherein the organic solvent is a mixture of THF and acetonitrile.

4. A method of claim 1 , wherein bringing the solution to supersaturation comprises slow addition of an anti-solvent, allowing the solution to cool, reducing the volume of the solution, or any combination thereof.

5. A method of claim 4 , wherein bringing the solution to supersaturation comprises cooling the solution to ambient temperature or lower.

6. A method of claim 1 , further comprising washing the crystals.

7. A method of claim 6 , wherein the washing comprises washing with a liquid selected from diethyl ether, THF, acetonitrile, and MTBE, or any combination thereof.

8. A method of claim 7 , wherein washing comprises washing with acetonitrile.

9. A method of claim 1 , wherein isolating the crystals comprises filtering the crystals.

10. A method of claim 1 , further comprising drying the crystals under reduced pressure.

11. A crystalline salt of a compound having a structure of Formula (II)

wherein the salt is a citrate salt, and wherein said crystalline compound has 2θ values of 4.40; 7.22; 9.12; 12.36; 13.35; 14.34; 15.54; 16.14; 16.54; 17.00; 18.24; 18.58; 19.70; 19.90; 20.30; 20.42; 21.84; 22.02; 23.34; 23.84; 24.04; 24.08; 24.48; 24.76; 25.48; 26.18; 28.14; 28.20; 28.64; 29.64; 31.04; 31.84; 33.00; 33.20; 34.06; 34.30; 34.50; 35.18; 37.48; 37.90; and 39.48.

12. A crystalline salt of claim 11 , having a DSC thermogram substantially as shown in FIG. 11 .

13. A crystalline salt of claim 11 , having a melting point of about 180 to about 190° C.

14. A crystalline salt of claim 13 , having a melting point of about 184 to about 188° C.

15. A crystalline salt of claim 11 , having an XRPD pattern substantially as shown in FIG. 12 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2013
From: PHIASIVONGSA, PASIT; SEHL, LOUIS C.; FULLER, WILLIAM DEAN; LAIDIG, GUY J.
To: PROTEOLIX, INC.
Reel/Frame 029764/0037 →
MERGER Recorded Feb 6, 2013
From: PROTEOLIX, INC.
To: ONYXTHERAPEUTICS, INC.
Reel/Frame 029764/0113 →
Continuity (4)
Continuation 12287043 · Oct 3, 2008
Provisional Application 61008987 · Dec 20, 2007
Provisional Application 60997613 · Oct 4, 2007
Related Publication 20130150290A1 · Jun 13, 2013